CLINICAL TRIALS PROFILE FOR DICLOFENAC EPOLAMINE
✉ Email this page to a colleague
All Clinical Trials for DICLOFENAC EPOLAMINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01380353 ↗ | Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine | Completed | Northwestern University | Early Phase 1 | 2011-06-01 | The purpose of this study is to look for ways to improve breast cancer treatment by giving breast cancer drugs through the skin of the breast. The drug used in this study is a diclofenac epolamine patch and is a nonsteroid anti-inflammatory pain reliever. The drug amount that gathers in the breast, after application of a patch to the skin of the breast, will be measured and compared to the amount that is found in the breast when the patch is applied to the skin of the belly. |
| NCT02132247 ↗ | Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries | Completed | IBSA Institut Biochimique SA | Phase 4 | 2014-05-01 | The primary purpose of this study is to determine whether Flector Patch is safe for use in children. The secondary purpose is to assess blood levels of diclofenac, the active ingredient in Flector Patch. |
| NCT02324270 ↗ | Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain | Completed | Actavis Inc. | Phase 3 | 2014-05-01 | To demonstrate the therapeutic efficacy of a generic diclofenac epolamine patch against Flector patch in the treatment of pain in subjects with minor ankle sprain |
| NCT03145259 ↗ | Evaluation of Bioavailability of Diclofenac Dermal Products | Completed | Food and Drug Administration (FDA) | Early Phase 1 | 2017-04-19 | The study will utilize already FDA-approved marketed diclofenac products in healthy adults to generate data for establishing rate of drug delivery comparisons between diclofenac epolamine patches and diclofenac sodium solution in healthy adults and to determine skin concentrations. |
| NCT03145259 ↗ | Evaluation of Bioavailability of Diclofenac Dermal Products | Completed | University of Maryland | Early Phase 1 | 2017-04-19 | The study will utilize already FDA-approved marketed diclofenac products in healthy adults to generate data for establishing rate of drug delivery comparisons between diclofenac epolamine patches and diclofenac sodium solution in healthy adults and to determine skin concentrations. |
| NCT03145259 ↗ | Evaluation of Bioavailability of Diclofenac Dermal Products | Completed | University of Maryland, Baltimore | Early Phase 1 | 2017-04-19 | The study will utilize already FDA-approved marketed diclofenac products in healthy adults to generate data for establishing rate of drug delivery comparisons between diclofenac epolamine patches and diclofenac sodium solution in healthy adults and to determine skin concentrations. |
| NCT05171673 ↗ | Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury | Recruiting | IBSA Institut Biochimique SA | Phase 3 | 2021-10-31 | A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety of the LicartTM topical system in pediatric and adult participants with minor soft tissue injuries. 150 male and female participants aged 6-16 and 18-45 with soft tissue injuries meeting the following criteria will be enrolled to evaluate the pharmacokinetics and safety of the Licart topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. The analgesic effects will also be evaluated of the topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. To collect principal investigator-reported global response to therapy. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DICLOFENAC EPOLAMINE
Condition Name
Clinical Trial Locations for DICLOFENAC EPOLAMINE
Trials by Country
Clinical Trial Progress for DICLOFENAC EPOLAMINE
Clinical Trial Phase
Clinical Trial Sponsors for DICLOFENAC EPOLAMINE
Sponsor Name
